Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Adamo

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Molecular Therapy. Methods & Clinical Development|September 29, 2025
CAR T cell engineering impacts antigen-independent activation and co-inhibitionChristoph Schultheiß, Simon Stücheli, Brenda Besemer, et al.
Frontiers in Neurology|December 5, 2022
Machine learning can predict mild cognitive impairment in Parkinson's diseaseMarianna Amboni, Carlo Ricciardi, Sarah Adamo, et al.
Nature Immunology|August 21, 2023
Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2Yves Zurbuchen, Jan Michler, Patrick Taeschler, et al.
Nature Immunology|April 27, 2023
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2Yves Zurbuchen, Jan Michler, Patrick Taeschler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 12, 2024
Direct Current Stimulation of Prefrontal Cortex Is Not Effective in Progressive Supranuclear Palsy: A Randomized TrialArianna Cappiello, Filomena Abate, Sarah Adamo, et al.
Allergy|May 14, 2022
T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19Patrick Taeschler, Sarah Adamo, Yun Deng, et al.
Allergy|April 1, 2022
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signaturesPatrick Taeschler, Carlo Cervia, Yves Zurbuchen, et al.
Allergy|April 22, 2021
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19Sarah Adamo, Stéphane Chevrier, Carlo Cervia, et al.
Nature Communications|January 26, 2022
Immunoglobulin signature predicts risk of post-acute COVID-19 syndromeCarlo Cervia, Yves Zurbuchen, Patrick Taeschler, et al.
Cell Reports. Medicine|February 1, 2021
A distinct innate immune signature marks progression from mild to severe COVID-19Stéphane Chevrier, Yves Zurbuchen, Carlo Cervia, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Therapy. Methods & Clinical Development|September 29, 2025
CAR T cell engineering impacts antigen-independent activation and co-inhibitionChristoph Schultheiß, Simon Stücheli, Brenda Besemer, et al.
Frontiers in Neurology|December 5, 2022
Machine learning can predict mild cognitive impairment in Parkinson's diseaseMarianna Amboni, Carlo Ricciardi, Sarah Adamo, et al.
Nature Immunology|August 21, 2023
Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2Yves Zurbuchen, Jan Michler, Patrick Taeschler, et al.
Nature Immunology|April 27, 2023
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2Yves Zurbuchen, Jan Michler, Patrick Taeschler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 12, 2024
Direct Current Stimulation of Prefrontal Cortex Is Not Effective in Progressive Supranuclear Palsy: A Randomized TrialArianna Cappiello, Filomena Abate, Sarah Adamo, et al.
Allergy|May 14, 2022
T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19Patrick Taeschler, Sarah Adamo, Yun Deng, et al.
Allergy|April 1, 2022
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signaturesPatrick Taeschler, Carlo Cervia, Yves Zurbuchen, et al.
Allergy|April 22, 2021
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19Sarah Adamo, Stéphane Chevrier, Carlo Cervia, et al.
Nature Communications|January 26, 2022
Immunoglobulin signature predicts risk of post-acute COVID-19 syndromeCarlo Cervia, Yves Zurbuchen, Patrick Taeschler, et al.
Cell Reports. Medicine|February 1, 2021
A distinct innate immune signature marks progression from mild to severe COVID-19Stéphane Chevrier, Yves Zurbuchen, Carlo Cervia, et al.
Pageof 3